Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
4'-phosphopantetheinyl transferase PptT is an essential enzyme in Mycobacterium tuberculosis that catalyzes the post-translational modification of various acyl carrier proteins (ACPs). It functions by transferring a 4'-phosphopantetheine moiety from coenzyme A to a conserved serine residue on target proteins, a process required to convert inactive apo-enzymes into their active holo-forms. This modification is critical for the activity of polyketide synthases and non-ribosomal peptide synthetases involved in the biosynthesis of mycolic acids, virulence-associated lipids, and the siderophore mycobactin. Because PptT is required for both the growth and persistence of the bacteria within the host, it is a highly validated therapeutic target for the treatment of tuberculosis. Small molecule inhibitors targeting PptT have shown potent bactericidal activity against both drug-sensitive and multidrug-resistant strains of M. tuberculosis by disrupting essential cell wall synthesis and nutrient acquisition pathways.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 4'-phosphopantetheinyl transferase PptT (PptT).